To satisfy the need for necessary number of patients in trials, SwedPedMed is also able to broaden the recruitment to other countries in Europe. SwedPedMed is part of the NordicPedMed which encompasses the corresponding national networks in Finland, Norway, Denmark and Iceland.
SwedPedMed is also represented in the European network (Paediatric Clinical Research Infrastructure Network; EPCT-RI) that has joined ECRIN to form a European organization for establishing and connecting a large number of clinical platforms with excellence in paediatric drug development (email@example.com). The three-year project which is funded by the European Union´s Horizon 2020 brings together ECRIN and the founding partners of the EPCT-RI to develop capacity for the management of multinational paediatric clinical trials. The new organisation started its work January 1st 2017.
SwedPedMed is also taking part in the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), which aims to bring relevant stakeholders together to discuss and make strategies to reduce barriers and improve opportunities for high-quality clinical studies in children in Europe and worldwide.
SwedPedMed and Karolinska Institutet is the Swedish representative and Swedish National Hub in the large collaborative European network c4c (conect4children)(https://conect4children.org). C4c which aims to facilitate the development of new drugs and other therapies for the entire paediatric population. This novel collaboration includes 33 academic and 10 industry partners from 20 European countries, and more than 50 third parties and around 500 affiliated partners.